The involvement of microRNAs in neurodegenerative diseases

Frontiers in Cellular Neuroscience

Volumn 7, Issue DEC, 2013, Pages

  Maciotta, Simona ^a,b   Meregalli, Mirella ^a   Torrente, Yvan ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; Biomarker; Huntington's disease; Microrna; Neurodegenerative diseases; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE 1; CYCLIN DEPENDENT KINASE 5; FIBROBLAST GROWTH FACTOR 20; GROWTH FACTOR; LEUCINE RICH REPEAT KINASE 2; MICRORNA; MICRORNA 146; MICRORNA 153; MICRORNA 184; MICRORNA 205; MICRORNA 206; MICRORNA 26B; MICRORNA 34A; MICRORNA 433; MICRORNA 7; MICRORNA 9; PRESENILIN; TAU PROTEIN; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BIOGENESIS; DEGENERATIVE DISEASE; DNA SPLICING; DOWN REGULATION; GAIN OF FUNCTION MUTATION; HUMAN; HUNTINGTON CHOREA; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROFILAMENT; NONHUMAN; PARKINSON DISEASE; POSTTRANSCRIPTIONAL GENE SILENCING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84891093032     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2013.00265     Document Type: Review

References (219)

1. Absalon, S., Kochanek, D. M., Raghavan, V., and Krichevsky, A. M. (2013). MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tauphosphorylation, and apoptosis in postmitotic neurons. J. Neurosci. 33, 14645-14659. doi: 10.1523/JNEUROSCI.1327-13.2013
2. Al-Chalabi, A., Andersen, P. M., Nilsson, P., Chioza, B., Andersson, J. L., Russ, C., et al. (1999). Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum. Mol. Genet. 8, 157-164. doi: 10.1093/hmg/ 8.2.157
3. Alexis, F., Pridgen, E., Molnar, L. K., and Farokhzad, O. C. (2008). Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5, 505-515. doi: 10.1021/mp800051m
4. Allen, T. A., Von Kaenel, S., Goodrich, J. A., and Kugel, J. F. (2004). The SINE-encoded mouse B2 RNA represses mRNA transcription in response to heat shock. Nat. Struct. Mol. Biol. 11, 816-821. doi: 10.1038/nsmb813
5. Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., and Wood, M. J. (2011). Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29, 341-345. doi: 10.1038/nbt.1807
6. Ambros, V., Lee, R. C., Lavanway, A., Williams, P. T., and Jewell, D. (2003). MicroRNAs and other tiny endogenous RNAs in C. elegans. Curr. Biol. 13, 807-818. doi: 10.1016/S0960-9822(03)00287-2
7. Bak, M., Silahtaroglu, A., Moller, M., Christensen, M., Rath, M. F., Skryabin, B., et al. (2008). MicroRNA expression in the adult mouse central nervous system. RNA 14, 432-444. doi: 10.1261/rna.783108
8. Balyasnikova, I. V., Yeomans, D. C., Mcdonald, T. B., and Danilov, S. M. (2002). Antibody-mediated lung endothelium targeting: in vivo model on primates. Gene Ther. 9, 282-290. doi: 10.1038/sj.gt.3301657
9. Bartel, B., and Bartel, D. P. (2003). MicroRNAs: at the root of plant development? Plant Physiol. 132, 709-717. doi: 10.1104/pp.103.023630
10. Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297. doi: 10.1016/S0092-8674(04)00045-5
11. Baskerville, S., and Bartel, D. P. (2005). Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11, 241-247. doi: 10.1261/rna.7240905
12. Bidros, D. S., Liu, J. K., and Vogelbaum, M. A. (2010). Future of convection-enhanced delivery in the treatment of brain tumors. Future Oncol. 6, 117-125. doi: 10.2217/fon.09.135
13. Boissonneault, V., Plante, I., Rivest, S., and Provost, P. (2009). MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J. Biol. Chem. 284, 1971-1981. doi: 10.1074/jbc.M807530200
14. Borchard, G. (2001). Chitosans for gene delivery. Adv. Drug Deliv. Rev. 52, 145-150. doi: 10.1016/S0169-409X(01)00198-3
15. Brouwers, N., Sleegers, K., and Van Broeckhoven, C. (2008). Molecular genetics of Alzheimer's disease: an update. Ann. Med. 40, 562-583. doi: 10.1080/07853890802186905
16. Buratti, E., De Conti, L., Stuani, C., Romano, M., Baralle, M., and Baralle, F. (2010). Nuclear factor TDP-43 can affect selected microRNA levels. FEBS J. 277, 2268-2281. doi: 10.1111/j.1742-4658.2010.07643.x
17. Butovsky, O., Siddiqui, S., Gabriely, G., Lanser, A. J., Dake, B., Murugaiyan, G., et al. (2012). Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J. Clin. Invest. 122, 3063-3087. doi: 10.1172/JCI62636
18. Campos-Melo, D., Droppelmann, C. A., He, Z., Volkening, K., and Strong, M. J. (2013). Altered microRNA expression profile in amyotrophic lateral sclerosis: a role in the regulation of NFL mRNA levels. Mol. Brain 6, 26. doi: 10.1186/1756-6606-6-26
19. Cao, Z., Henzel, W. J., and Gao, X. (1996). IRAK: a kinase associated with the interleukin-1 receptor. Science 271, 1128-1131. doi: 10.1126/science.271.5252.1128
20. Cardo, L. F., Coto, E., De Mena, L., Ribacoba, R., Moris, G., Menendez, M., et al. (2013). Profile of microRNAs in the plasma of Parkinson's disease patients and healthy controls. J. Neurol. 260, 1420-1422. doi: 10.1007/s00415-013-6900-8
21. Carrington, J. C., and Ambros, V. (2003). Role of microRNAs in plant and animal development. Science 301, 336-338. doi: 10.1126/science.1085242
22. Catarecha, P., Segura, M. D., Franco-Zorrilla, J. M., Garcia-Ponce, B., Lanza, M., Solano, R., et al. (2007). A mutant of the Arabidopsis phosphate transporter PHT1;1 displays enhanced arsenic accumulation. Plant Cell 19, 1123-1133. doi: 10.1105/tpc.106.041871
23. Cattaneo, E., Zuccato, C., and Tartari, M. (2005). Normal huntingtin function: an alternative approach to Huntington's disease. Nat. Rev. Neurosci. 6, 919-930. doi: 10.1038/nrn1806
24. Cha, J. H. (2007). Transcriptional signatures in Huntington's disease. Prog. Neurobiol. 83, 228-248. doi: 10.1016/j.pneurobio.2007.03.004
25. Chen, J. F., Mandel, E. M., Thomson, J. M., Wu, Q., Callis, T. E., Hammond, S. M., et al. (2006). The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38, 228-233. doi: 10.1038/ ng1725
26. Chen, P. Y., Liu, H. L., Hua, M. Y., Yang, H. W., Huang, C. Y., Chu, P. C., et al. (2010). Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment. Neuro Oncol. 12, 1050-1060. doi:10.1093/neuonc/noq054
27. Cheng, P. H., Li, C. L., Chang, Y. F., Tsai, S. J., Lai, Y. Y., Chan, A. W., et al. (2013). miR-196a Ameliorates Phenotypes of Huntington Disease in Cell, Transgenic Mouse, and Induced Pluripotent Stem Cell Models. Am. J. Hum. Genet. 93, 306-312. doi: 10.1016/j.ajhg.2013.05.025
28. Cho, H. J., Liu, G., Jin, S. M., Parisiadou, L., Xie, C., Yu, J., et al. (2013). MicroRNA-205 regulates the expression of Parkinson's disease-related leucinerich repeat kinase 2 protein. Hum. Mol. Genet. 22, 608-620. doi: 10.1093/ hmg/dds470
29. Chu, T. C., Twu, K. Y., Ellington, A. D., and Levy, M. (2006). Aptamer mediated siRNA delivery. Nucleic Acids Res. 34:e73. doi: 10.1093/nar/gkl388
30. Cogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., et al. (2008). Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J. Alzheimers Dis. 14, 27-41.
31. Crist, C. G., and Buckingham, M. (2010). Megarole for microRNA in muscle disease. Cell Metab. 12, 425-426. doi: 10.1016/j.cmet.2010.10.007
32. Crooke, S. T. (2004). Progress in antisense technology. Annu. Rev. Med. 55, 61-95. doi: 10.1146/annurev.med.55.091902.104408
33. Davis, E., Caiment, F., Tordoir, X., Cavaille, J., Ferguson-Smith, A., Cockett, N., et al. (2005). RNAi-mediated allelic trans-interaction at the imprinted Rtl1/Peg11 locus. Curr. Biol. 15, 743-749. doi: 10.1016/j.cub.2005.02.060
34. De Felice, B., Guida, M., Guida, M., Coppola, C., De Mieri, G., and Cotrufo, R. (2012). A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis. Gene 508, 35-40. doi: 10.1016/j.gene.2012.07.058
35. Delay, C., Calon, F., Mathews, P., and Hebert, S. S. (2011). Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function. Mol. Neurodegener. 6, 70. doi: 10.1186/1750-1326-6-70
36. Dickson, J. R., Kruse, C., Montagna, D. R., Finsen, B., and Wolfe, M. S. (2013). Alternative polyadenylation and miR-34 family members regulate tau expression. J. Neurochem. 127, 739-749. doi: 10.1111/jnc.12437
37. Donev, R., Newall, A., Thome, J., and Sheer, D. (2007). A role for SC35 and hnRNPA1 in the determination of amyloid precursor protein isoforms. Mol. Psychiatry 12, 681-690. doi: 10.1038/sj.mp.4001971
38. Doxakis, E. (2010). Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J. Biol. Chem. 285, 12726-12734. doi: 10.1074/jbc.M109.086827
39. Dreyfuss, G., Kim, V. N., and Kataoka, N. (2002). Messenger-RNA-binding proteins and the messages they carry. Nat. Rev. Mol. Cell Biol. 3, 195-205. doi: 10.1038/nrm760
40. Drubin, D. G., and Kirschner, M. W. (1986). Tau protein function in living cells. J. Cell Biol. 103, 2739-2746. doi: 10.1083/jcb.103.6.2739
41. Ebert, M. S., Neilson, J. R., and Sharp, P. A. (2007). MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 4, 721-726. doi: 10.1038/nmeth1079
42. Eisenberg, I., Alexander, M. S., and Kunkel, L. M. (2009). miRNAS in normal and diseased skeletal muscle. J. Cell. Mol. Med. 13, 2-11. doi: 10.1111/j.15824934.2008.00524.x
43. Elbashir, S. M., Lendeckel, W., and Tuschl, T. (2001a). RNA interference is mediated by 21-and 22-nucleotide RNAs. Genes Dev. 15, 188-200. doi: 10.1101/gad.862301
44. Elbashir, S. M., Martinez, J., Patkaniowska, A., Lendeckel, W., and Tuschl, T. (2001b). Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20, 6877-6888. doi: 10.1093/emboj/20.23.6877
45. Espinoza, C. A., Allen, T. A., Hieb, A. R., Kugel, J. F., and Goodrich, J. A. (2004). B2 RNA binds directly to RNA polymerase II to repress transcript synthesis. Nat. Struct. Mol. Biol. 11, 822-829. doi: 10.1038/nsmb812
46. Fang, M., Wang, J., Zhang, X., Geng, Y., Hu, Z., Rudd, J. A., et al. (2012). The miR-124 regulates the expression of BACE1/beta-secretase correlated with cell death in Alzheimer's disease. Toxicol. Lett. 209, 94-105. doi: 10.1016/j.toxlet.2011.11.032
47. Fejes-Toth, K., Sotirova, V., Sachidanandam R., Assaf, G., Hannon, G., and Kapranov, P. (2009). Post-transcriptional processing generates a diversity of 5'-modified long and short RNAs. Nature 457, 1028-1032. doi: 10.1038/nature07759
48. Feng, J., Bi, C., Clark, B. S., Mady, R., Shah, P., and Kohtz, J. D. (2006). The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator. Genes Dev. 20, 1470-1484. doi: 10.1101/gad.1416106
49. Figlewicz, D. A., Krizus, A., Martinoli, M. G., Meininger, V., Dib, M., Rouleau, G. A., et al. (1994). Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum. Mol. Genet. 3, 1757-1761. doi: 10.1093/hmg/3.10.1757
50. Flannery, S., and Bowie, A. G. (2010). The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling. Biochem. Pharmacol. 80, 1981-1991. doi: 10.1016/j.bcp.2010.06.020
51. Fox, M. A., Sanes, J. R., Borza, D. B., Eswarakumar, V. P., Fassler, R., Hudson, B. G., et al. (2007). Distinct target-derived signals organize formation, maturation, and maintenance of motor nerve terminals. Cell 129, 179-193. doi: 10.1016/j.cell.2007.02.035
52. Franco-Zorrilla, J. M., Valli, A., Todesco, M., Mateos, I., Puga, M. I., Rubio-Somoza, I., et al. (2007). Target mimicry provides a new mechanism for regulation of microRNA activity. Nat Genet. 39, 1033-1037. doi: 10.1038/ng2079
53. Galter, D., Westerlund, M., Carmine, A., Lindqvist, E., Sydow, O., and Olson, L. (2006). LRRK2 expression linked to dopamine-innervated areas. Ann. Neurol. 59, 714-719. doi: 10.1002/ana.20808
54. Gaughwin, P. M., Ciesla, M., Lahiri, N., Tabrizi, S. J., Brundin, P., and Bjorkqvist, M. (2011). Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease. Hum. Mol. Genet. 20, 2225-2237. doi: 10.1093/hmg/ddr111
55. Geekiyanage, H., and Chan, C. (2011). MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid beta, novel targets in sporadic Alzheimer's disease. J. Neurosci. 31, 14820-14830. doi: 10.1523/JNEUROSCI.3883-11.2011
56. Gehrke, S., Imai, Y., Sokol, N., and Lu, B. (2010). Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature 466, 637-641. doi: 10.1038/nature09191
57. Giordana, M. T., Piccinini, M., Grifoni, S., De Marco, G., Vercellino, M., Magistrello, M., et al. (2010). TDP-43 redistribution is an early event in sporadic amyotrophic lateral sclerosis. Brain Pathol. 20, 351-360. doi: 10.1111/j.17503639.2009.00284.x
58. Golde, T. E., Estus, S., Usiak, M., Younkin, L. H., and Younkin, S. G. (1990). Expression of beta amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer's disease using PCR. Neuron 4, 253-267. doi: 10.1016/0896-6273(90)90100-T
59. Gregory, R. I., Yan, K. P., Amuthan, G., Chendrimada, T., Doratotaj, B., Cooch, N., et al. (2004). The Microprocessor complex mediates the genesis of microRNAs. Nature 432, 235-240. doi: 10.1038/nature03120
60. Hammond, S. M., Bernstein, E., Beach, D., and Hannon, G. J. (2000). An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404, 293-296. doi: 10.1038/35005107
61. Hanger, D. P., and Noble, W. (2011). Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation. Int. J. Alzheimers Dis. 2011, 352805. doi: 10.4061/2011/352805
62. Hannun, Y. A., and Obeid, L. M. (2008). Principles of bioactive lipid signalling: lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. 9, 139-150. doi: 10.1038/nrm2329
63. Haramati, S., Chapnik, E., Sztainberg, Y., Eilam, R., Zwang, R., Gershoni, N., et al. (2010). miRNA malfunction causes spinal motor neuron disease. Proc. Natl. Acad. Sci. U.S.A. 107, 13111-13116. doi: 10.1073/pnas.1006151107
64. Harper, S. Q., Staber, P. D., He, X., Eliason, S. L., Martins, I. H., Mao, Q., et al. (2005). RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc. Natl. Acad. Sci. U.S.A. 102, 5820-5825. doi: 10.1073/pnas.0501507102
65. Hass, M. R., Sato, C., Kopan, R., and Zhao, G. (2009). Presenilin: RIP and beyond. Semin. Cell Dev. Biol. 20, 201-210. doi: 10.1016/j.semcdb.2008.11.014
66. Hebert, S. S., and De Strooper, B. (2007). Molecular biology. miRNAs in neurode-generation. Science 317, 1179-1180. doi: 10.1126/science.1148530
67. Hebert, S. S., and De Strooper, B. (2009). Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci. 32, 199-206. doi: 10.1016/j.tins.2008.12.003
68. Hebert, S. S., Horre, K., Nicolai, L., Papadopoulou, A. S., Mandemakers, W., Silahtaroglu, A. N., et al. (2008). Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. U.S.A. 105, 6415-6420. doi: 10.1073/pnas.0710263105
69. Hellwig, S., and Bass, B. L. (2008) A starvation-induced noncoding RNA modulates expression of Dicer-regulated genes. Proc. Natl. Acad. Sci. U.S.A. 105, 12897-12902 doi: 10.1073/pnas.0805118105
70. Hong, M., and Lee, V. M. (1997). Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J. Biol. Chem. 272, 19547-19553. doi: 10.1074/jbc.272.31.19547
71. Hu, Y. K., Wang, X., Li, L., Du, Y. H., Ye, H. T., and Li, C. Y. (2013). MicroRNA-98 induces an Alzheimer's disease-like disturbance by targeting insulin-like growth factor 1. Neurosci. Bull. 29, 745-751. doi: 10.1007/s12264-013-1348-5
72. Hunter, C., and Poethig, R. S. (2003). miSSING LINKS: miRNAs and plant development. Curr. Opin. Genet. Dev. 13, 372-378. doi: 10.1016/S0959-437X(03) 00081-9
73. Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., Van Eersel, J., et al. (2010). Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 142, 387-397. doi: 10.1016/j.cell.2010.06.036
74. Jacobsen, J. S., Blume, A. J., and Vitek, M. P. (1991). Quantitative measurement of alternatively spliced amyloid precursor protein mRNA expression in Alzheimer's disease and normal brain by S1 nuclease protection analysis. Neurobiol. Aging 12, 585-592. doi: 10.1016/0197-4580(91)90090-7
75. Jakes, R., Spillantini, M. G., and Goedert, M. (1994). Identification of two distinct synucleins from human brain. FEBS Lett. 345, 27-32. doi: 10.1016/00145793(94)00395-5
76. Jayadev, S., Case, A., Alajajian, B., Eastman, A. J., Moller, T., and Garden, G. A. (2013). Presenilin 2 influences miR146 level and activity in microglia. J. Neurochem. 127, 592-599. doi: 10.1111/jnc.12400
77. Jayadev, S., Case, A., Eastman, A. J., Nguyen, H., Pollak, J., Wiley, J. C., et al. (2010). Presenilin 2 is the predominant gamma-secretase in microglia and modulates cytokine release. PLoS ONE 5:e15743. doi: 10.1371/journal.pone.0015743
78. Jere, D., Arote, R., Jiang, H. L., Kim, Y. K., Cho, M. H., and Cho, C. S. (2009). Bioreducible polymers for efficient gene and siRNA delivery. Biomed. Mater. 4:025020. doi: 10.1088/1748-6041/4/2/025020
79. Johnson, R. and Bucley, N. J. (2009a). Gene dysregulation in Huntington's disease: REST, microRNAs and beyond. Neuromolecular Med. 11, 183-99. doi: 10.1007/s12017-009-8063-4
80. Johnson, R., Teh CH., Jia H., Vanisri RR., Pandey T., Lu ZH., et al. (2009b) Regulation of neural macroRNAs by the transcriptional repressor REST. RNA 15, 85-96. doi: 10.1261/rna.1127009
81. Johnson, R., Noble, W., Tartaglia, G. G., and Buckley, N. J. (2012). Neurodegeneration as an RNA disorder. Prog. Neurobiol. 99, 293-315. doi: 10.1016/j.pneurobio.2012.09.006
82. Johnson, R., Zuccato, C., Belyaev, N. D., Guest, D. J., Cattaneo, E., and Buckley, N. J. (2008). A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiol. Dis. 29, 438-445. doi: 10.1016/j.nbd.2007.11.001
83. Juliano, R., Alam, M. R., Dixit, V., and Kang, H. (2008). Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Res. 36, 4158-4171. doi: 10.1093/nar/gkn342
84. Juliano, R. L. (2005). Peptide-oligonucleotide conjugates for the delivery of antisense and siRNA. Curr. Opin. Mol. Ther. 7, 132-136.
85. Julien, J. P. (1999). Neurofilament functions in health and disease. Curr. Opin. Neurobiol. 9, 554-560. doi: 10.1016/S0959-4388(99)00004-5
86. Junn, E., Lee, K. W., Jeong, B. S., Chan, T. W., Im, J. Y., and Mouradian, M. M. (2009). Repression of alpha-synuclein expression and toxicity by microRNA-7. Proc. Natl. Acad. Sci. U.S.A. 106, 13052-13057. doi: 10.1073/pnas. 0906277106
87. Kabashi, E., Valdmanis, P. N., Dion, P., Spiegelman, D., Mcconkey, B. J., Vande Velde, C., et al. (2008). TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40, 572-574. doi: 10.1038/ng.132
88. Kapranov, P., Cheng, J., Dike, S., Nix, D. A., Duttagupta, R., Willingham, A. T., et al. (2007). RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 316, 1484-1488. doi: 10.1126/science.1138341
89. Kelly, T. K., De Carvalho, D. D., and Jones, P. A. (2010). Epigenetic modifications as therapeutic targets. Nat. Biotechnol. 28, 1069-1078. doi: 10.1038/ nbt.1678
90. Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., et al. (2011). Amyotrophic lateral sclerosis. Lancet 377, 942-955. doi: 10.1016/S01406736(10)61156-7
91. Kim, D. H., and Rossi, J. J. (2007). Strategies for silencing human disease using RNA interference. Nat. Rev. Genet. 8, 173-184. doi: 10.1038/nrg2006
92. Kim, J., Inoue, K., Ishii, J., Vanti, W. B., Voronov, S. V., Murchison, E., et al. (2007). A MicroRNA feedback circuit in midbrain dopamine neurons. Science 317, 1220-1224. doi: 10.1126/science.1140481
93. Kluiver, J., Gibcus, J. H., Hettinga, C., Adema, A., Richter, M. K., Halsema, N., et al. (2012a). Rapid generation of microRNA sponges for microRNA inhibition. PLoS ONE 7:e29275. doi: 10.1371/journal.pone.0029275
94. Kluiver, J., Slezak-Prochazka, I., Smigielska-Czepiel, K., Halsema, N., Kroesen, B. J., and Van Den Berg, A. (2012b). Generation of miRNA sponge constructs. Methods 58, 113-117. doi: 10.1016/j.ymeth.2012.07.019
95. Kohlmaier, A., Savarese, F., Lachner, M., Martens, J., Jenuwein, T., and Wutz, A. (2004). A chromosomal memory triggered by Xist regulates histone methylation in X inactivation. PLoS Biol. 2:E171. doi: 10.1371/journal.pbio.0020171
96. Kosik, K. S., Joachim, C. L., and Selkoe, D. J. (1986). Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 83, 4044-4048. doi: 10.1073/pnas.83.11.4044
97. Koval, E. D., Shaner, C., Zhang, P., Du Maine, X., Fischer, K., Tay, J., et al. (2013). Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. Hum. Mol. Genet. 22, 4127-4135. doi: 10.1093/ hmg/ddt261
98. Krichevsky, A. M., King, K. S., Donahue, C. P., Khrapko, K., and Kosik, K. S. (2003). A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 9, 1274-1281. doi: 10.1261/rna.5980303
99. Krutzfeldt, J., Kuwajima, S., Braich, R., Rajeev, K. G., Pena, J., Tuschl, T., et al. (2007). Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res. 35, 2885-2892. doi: 10.1093/nar/ gkm024
100. Krutzfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., et al. (2005). Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685-689. doi: 10.1038/nature04303
101. Kumar, P., Ban, H. S., Kim, S. S., Wu, H., Pearson, T., Greiner, D. L., et al. (2008). T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 134, 577-586. doi: 10.1016/j.cell.2008.06.034
102. Kwiatkowski, T. J., Jr., Bosco, D. A., Leclerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., et al. (2009). Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205-1208. doi: 10.1126/science.1166066
103. Lagier-Tourenne, C., Polymenidou, M., and Cleveland, D. W. (2010). TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 19, R46-R64. doi: 10.1093/hmg/ddq137
104. Lagos-Quintana, M., Rauhut, R., Lendeckel, W., and Tuschl, T. (2001). Identification of novel genes coding for small expressed RNAs. Science 294, 853-858. doi: 10.1126/science.1064921
105. Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W., and Tuschl, T. (2002). Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12, 735-739. doi: 10.1016/S0960-9822(02)00809-6
106. Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., et al. (2007). A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401-1414. doi: 10.1016/j.cell. 2007.04.040
107. Lau, N. C., Lim, L. P., Weinstein, E. G., and Bartel, D. P. (2001). An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294, 858-862. doi: 10.1126/science.1065062
108. Lee, R. C., Feinbaum, R. L., and Ambros, V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854. doi: 10.1016/0092-8674(93)90529-Y
109. Lee, S. J., Liyanage, U., Bickel, P. E., Xia, W., Lansbury, P. T. Jr., and Kosik, K. S. (1998). A detergent-insoluble membrane compartment contains A beta in vivo. Nat. Med. 4, 730-734. doi: 10.1038/nm0698-730
110. Lee, V. M., Goedert, M., and Trojanowski, J. Q. (2001). Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159. doi: 10.1146/annurev.neuro.24.1.1121
111. Li, Z., Lu, Y., Xu, X. L., and Gao, F. B. (2013). The FTD/ALS-associated RNA-binding protein TDP-43 regulates the robustness of neuronal specification through microRNA-9a in Drosophila. Hum. Mol. Genet. 22, 218-225. doi: 10.1093/hmg/dds420
112. Liem, R. K., and Messing, A. (2009). Dysfunctions of neuronal and glial intermediate filaments in disease. J. Clin. Invest. 119, 1814-1824. doi: 10.1172/ JCI38003
113. Lin, X., Parisiadou, L., Gu, X. L., Wang, L., Shim, H., Sun, L., et al. (2009). Leucinerich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein. Neuron 64, 807-827. doi: 10.1016/j.neuron.2009.11.006
114. Ling, S. C., Albuquerque, C. P., Han, J. S., Lagier-Tourenne, C., Tokunaga, S., Zhou, H., et al. (2010). ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc. Natl. Acad. Sci. U.S.A. 107, 13318-13323. doi: 10.1073/pnas. 1008227107
115. Lipovich, L., Johnson, R., and Lin, C. Y. (2010). MacroRNA underdogs in a microRNA world: evolutionary, regulatory, and biomedical significance of mammalian long non-protein-coding RNA. Biochim. Biophys. Acta 1799, 597-615. doi: 10.1016/j.bbagrm.2010.10.001
116. Liu, H. L., Hua, M. Y., Chen, P. Y., Chu, P. C., Pan, C. H., Yang, H. W., et al. (2010). Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology 255, 415-425. doi: 10.1148/radiol.10090699
117. Long, J. M., and Lahiri, D. K. (2011). MicroRNA-101 downregulates Alzheimer's amyloid-beta precursor protein levels in human cell cultures and is differentially expressed. Biochem. Biophys. Res. Commun. 404, 889-895. doi: 10.1016/j.bbrc.2010.12.053
118. Lukiw, W. J. (2007). Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport 18, 297-300. doi: 10.1097/WNR.0b013e32 80148e8b
119. Maciotta, S., Meregalli, M., Cassinelli, L., Parolini, D., Farini, A., Fraro, G. D., et al. (2012). Hmgb3 is regulated by microRNA-206 during muscle regeneration. PLoS ONE 7:e43464. doi: 10.1371/journal.pone. 0043464
120. Mahato, R. I., Kawabata, K., Takakura, Y., and Hashida, M. (1995). In vivo disposition characteristics of plasmid DNA complexed with cationic liposomes. J. Drug Target. 3, 149-157. doi: 10.3109/10611869509059214
121. Makeyev, E. V., Zhang, J., Carrasco, M. A., and Maniatis, T. (2007). The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol. Cell 27, 435-448. doi: 10.1016/j.molcel.2007.07.015
122. Makimura, H., Mizuno, T. M., Mastaitis, J. W., Agami, R., and Mobbs, C. V. (2002). Reducing hypothalamic AGRP by RNA interference increases metabolic rate and decreases body weight without influencing food intake. BMC Neurosci. 3:18. doi: 10.1186/1471-2202-3-18
123. Malumbres, R., Sarosiek, K. A., Cubedo, E., Ruiz, J. W., Jiang, X., Gascoyne, R. D., et al. (2009). Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood 113, 3754-3764. doi: 10.1182/blood-2008-10-184077
124. Margis, R., Margis, R., and Rieder, C. R. (2011). Identification of blood microRNAs associated to Parkinsonis disease. J. Biotechnol. 152, 96-101. doi: 10.1016/j.jbiotec.2011.01.023
125. Mariner, P. D., Walters, R. D., Espinoza, C. A., Drullinger, L. F., Wagner, S. D., Kugel, J. F., et al. (2008). Human Alu RNA is a modular transacting repressor of mRNA transcription during heat shock. Mol. Cell 29, 499-509. doi: 10.1016/j.molcel.2007.12.013
126. Marti, E., Pantano, L., Banez-Coronel, M., Llorens, F., Minones-Moyano, E., Porta, S., et al. (2010). A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing. Nucleic Acids Res. 38, 7219-7235. doi: 10.1093/nar/gkq575
127. Martinez, J., Patkaniowska, A., Urlaub, H., Luhrmann, R., and Tuschl, T. (2002). Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 110, 563-574. doi: 10.1016/S0092-8674(02) 00908-X
128. Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., et al. (2000). Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265-1269. doi: 10.1126/science.287. 5456.1265
129. Matkovich, S. J., Van Booven, D. J., Youker, K. A., Torre-Amione, G., Diwan, A., Eschenbacher, W. H., et al. (2009). Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation 119, 1263-1271. doi: 10.1161/CIRCULATIONAHA.108.813576
130. Mckhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944. doi: 10.1212/WNL.34.7.939
131. Melrose, H., Lincoln, S., Tyndall, G., Dickson, D., and Farrer, M. (2006). Anatomical localization of leucine-rich repeat kinase 2 in mouse brain. Neuroscience 139, 791-794. doi: 10.1016/j.neuroscience.2006. 01.017
132. Minones-Moyano, E., Porta, S., Escaramis, G., Rabionet, R., Iraola, S., Kagerbauer, B., et al. (2011). MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Hum. Mol. Genet. 20, 3067-3078. doi: 10.1093/hmg/ddr210
133. Mori, F., Anji, K., Oshimoto, M., Akahashi, H., and Wakabayashi, K. (2002). Demonstration of alpha-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment. Exp. Neurol. 176, 98-104. doi: 10.1006/exnr. 2002.7929
134. Morlando, M., Dini Modigliani, S., Torrelli, G., Rosa, A., Di Carlo, V., Caffarelli, E., et al. (2012). FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment. EMBO J. 31, 4502-4510. doi: 10.1038/emboj.2012.319
135. Mouradian, M. M. (2012). MicroRNAs in Parkinson's disease. Neurobiol. Dis. 46, 279-284. doi: 10.1016/j.nbd.2011.12.046
136. Mucke, L., and Selkoe, D. J. (2011). Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction. Cold Spring Harb. Perspect. Med. 2:a006338. doi: 10.1101/cshperspect.a006338
137. Neve, R. L., Rogers, J., and Higgins, G. A. (1990). The Alzheimer amyloid precursor-related transcript lacking the beta/A4 sequence is specifically increased in Alzheimer's disease brain. Neuron 5, 329-338. doi: 10.1016/08966273(90)90169-G
138. Ningaraj, N. S., Salimath, B. P., Sankpal, U. T., Perera, R., and Vats, T. (2007). Targeted brain tumor treatment-current perspectives. Drug Target Insights 2, 197-207.
139. Nukina, N., and Ihara, Y. (1986). One of the antigenic determinants of paired helical filaments is related to tau protein. J. Biochem. 99, 1541-1544.
140. Nunez-Iglesias, J., Liu, C. C., Morgan, T. E., Finch, C. E., and Zhou, X. J. (2010). Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation. PLoS ONE 5:e8898. doi: 10.1371/journal.pone.0008898
141. Nykanen, A., Haley, B., and Zamore, P. D. (2001). ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell 107, 309-321. doi: 10.1016/S0092-8674(01)00547-5
142. Ohmachi, S., Mikami, T., Konishi, M., Miyake, A., and Itoh, N. (2003). Preferential neurotrophic activity of fibroblast growth factor-20 for dopaminergic neurons through fibroblast growth factor receptor-1c. J. Neurosci. Res. 72, 436-443. doi: 10.1002/jnr.10592
143. Ohmachi, S., Watanabe, Y., Mikami, T., Kusu, N., Ibi, T., Akaike, A., et al. (2000). FGF-20, a novel neurotrophic factor, preferentially expressed in the substantia nigra pars compacta of rat brain. Biochem. Biophys. Res. Commun. 277, 355-360. doi: 10.1006/bbrc.2000.3675
144. Ooi, L., and Wood, I. C. (2007). Chromatin crosstalk in development and disease: lessons from REST. Nat. Rev. Genet. 8, 544-554. doi: 10.1038/ nrg2100
145. * regulates REST and CoREST and is downregulated in Huntington's disease. J. Neurosci. 28, 14341-14346. doi: 10.1523/JNEUROSCI.2390-08.2008
146. Palm, T., Bahnassawy, L., and Schwamborn, J. (2012). MiRNAs and neural stem cells: a team to treat Parkinson's disease? RNA Biol. 9, 720-730. doi: 10.4161/rna.19984
147. Palop, J. J., and Mucke, L. (2010). Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat. Neurosci. 13, 812-818. doi: 10.1038/nn.2583
148. Papagiannakopoulos, T., and Kosik, K. S. (2009). MicroRNA-124: micromanager of neurogenesis. Cell Stem Cell 4, 375-376. doi: 10.1016/j.stem.2009. 04.007
149. Pardridge, W. M. (2007). shRNA and siRNA delivery to the brain. Adv. Drug Deliv. Rev. 59, 141-152. doi: 10.1016/j.addr.2007.03.008
150. Parisiadou, L., Xie, C., Cho, H. J., Lin, X., Gu, X. L., Long, C. X., et al. (2009). Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis. J. Neurosci. 29, 13971-13980. doi: 10.1523/JNEUROSCI.3799-09.2009
151. Pasquinelli, A. E., Reinhart, B. J., Slack, F., Martindale, M. Q., Kuroda, M. I., Maller, B., et al. (2000). Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408, 86-89. doi: 10.1038/35040556
152. Patel, N., Hoang, D., Miller, N., Ansaloni, S., Huang, Q., Rogers, J. T., et al. (2008). MicroRNAs can regulate human APP levels. Mol. Neurodegener. 3:10. doi: 10.1186/1750-1326-3-10
153. Pesiridis, G. S., Lee, V. M., and Trojanowski, J. Q. (2009). Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. Hum. Mol. Genet. 18, R156-R162. doi: 10.1093/hmg/ddp303
154. Plath, K., Fang, J., Mlynarczyk-Evans, S. K., Cao, R., Worringer, K. A., Wang, H., et al. (2003). Role of histone H3 lysine 27 methylation in X inactivation. Science 300, 131-135. doi: 10.1126/science.1084274
155. Ponting, C. P., Oliver, P. L., and Reik, W. (2009). Evolution and functions of long noncoding RNAs. Cell 136, 629-641. doi: 10.1016/j.cell.2009.02.006
156. Pushparaj, P. N., Aarthi, J. J., Manikandan, J., and Kumar, S. D. (2008). siRNA, miRNA, and shRNA: in vivo applications. J. Dent. Res. 87, 992-1003. doi: 10.1177/154405910808701109
157. Ralph, G. S., Radcliffe, P. A., Day, D. M., Carthy, J. M., Leroux, M. A., Lee, D. C., et al. (2005). Silencing mutant SOD1 using RNAi protects against neurode-generation and extends survival in an ALS model. Nat. Med. 11, 429-433. doi: 10.1038/nm1205
158. Rao, P. K., Kumar, R. M., Farkhondeh, M., Baskerville, S., and Lodish, H. F. (2006). Myogenic factors that regulate expression of muscle-specific microRNAs. Proc. Natl. Acad. Sci. U.S.A. 103, 8721-8726. doi: 10.1073/pnas.0602831103
159. Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., and Ferreira, A. (2002). Tau is essential to beta -amyloid-induced neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 99, 6364-6369. doi: 10.1073/pnas.092136199
160. Reinhart, B. J., and Bartel, D. P. (2002). Small RNAs correspond to centromere heterochromatic repeats. Science 297, 1831. doi: 10.1126/science.1077183
161. Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., et al. (2007). Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316, 750-754. doi: 10.1126/science.1141736
162. Rockenstein, E. M., Mcconlogue, L., Tan, H., Power, M., Masliah, E., and Mucke, L. (1995). Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease. J. Biol. Chem. 270, 28257-28267. doi: 10.1074/jbc. 270.47.28257
163. Rosario, P. W. (2010). Normal values of serum IGF-1 in adults: results from a Brazilian population. Arq. Bras. Endocrinol. Metabol. 54, 477-481. doi: 10.1590/S0004-27302010000500008
164. Saido, T., and Leissring, M. A. (2012). Proteolytic degradation of amyloid beta-protein. Cold Spring Harb. Perspect. Med. 2:a006379. doi: 10.1101/cshper-spect.a006379
165. Saiki, S., Sato, S., and Hattori, N. (2011). Molecular pathogenesis of Parkinson's disease: update. J. Neurol. Neurosurg. Psychiatry 83, 430-436. doi: 10.1136/jnnp2011-301205
166. Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., et al. (2009). Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat. Genet. 41, 1303-1307. doi: 10.1038/ng.485
167. Savas, J. N., Makusky, A., Ottosen, S., Baillat, D., Then, F., Krainc, D., et al. (2008). Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies. Proc. Natl. Acad. Sci. U.S.A. 105, 10820-10825. doi: 10.1073/pnas.0800658105
168. Schenk, D., Basi, G. S., and Pangalos, M. N. (2012). Treatment strategies targeting amyloid beta-protein. Cold Spring Harb. Perspect. Med. 2:a006387. doi: 10.1101/cshperspect.a006387
169. Schipper, H. M., Maes, O. C., Chertkow, H. M., and Wang, E. (2007). MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regul. Syst. Biol. 1, 263-274.
170. Schwarz, D. S., Hutvagner, G., Haley, B., and Zamore, P. D. (2002). Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways. Mol. Cell 10, 537-548. doi: 10.1016/S1097-2765(02) 00651-2
171. Sempere, L. F., Freemantle, S., Pitha-Rowe, I., Moss, E., Dmitrovsky, E., and Ambros, V. (2004). Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol. 5:R13. doi: 10.1186/gb-2004-5-3-r13
172. Shamovsky, I., Ivannikov, M., Kandel, E. S., Gershon, D., and Nudler, E. (2006). RNA-mediated response to heat shock in mammalian cells. Nature 440, 556-560. doi: 10.1038/nature04518
173. Shen, Y. (2008). Advances in the development of siRNA-based therapeutics for cancer. IDrugs 11, 572-578.
174. Shioya, M., Obayashi, S., Tabunoki, H., Arima, K., Saito, Y., Ishida, T., et al. (2010). Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. Neuropathol. Appl. Neurobiol. 36, 320-330. doi: 10.1111/j.13652990.2010.01076.x
175. Shtilbans, A., and Henchcliffe, C. (2012). Biomarkers in Parkinson's disease: an update. Curr. Opin. Neurol. 25, 460-465. doi: 10.1097/WCO.0b013e32 83550c0d
176. Silva, J., Mak, W., Zvetkova, I., Appanah, R., Nesterova, T. B., Webster, Z., et al. (2003). Establishment of histone h3 methylation on the inactive X chromosome requires transient recruitment of Eed-Enx1 polycomb group complexes. Dev. Cell 4, 481-495. doi: 10.1016/S1534-5807(03)00068-6
177. Simon-Sanchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., et al. (2009). Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet. 41, 1308-1312. doi: 10.1038/ng.487
178. Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., et al. (2003). alpha-Synuclein locus triplication causes Parkinson's disease. Science 302, 841. doi: 10.1126/science.1090278
179. Sinha, M., Mukhopadhyay, S., and Bhattacharyya, N. P. (2012). Mechanism(s) of alteration of micro RNA expressions in Huntington's disease and their possible contributions to the observed cellular and molecular dysfunctions in the disease. Neuromolecular Med. 14, 221-243. doi: 10.1007/s12017-012-8183-0
180. Skog, J., Wurdinger, T., Van Rijn, S., Meijer, D. H., Gainche, L., Sena-Esteves, M., et al. (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470-1476. doi: 10.1038/ncb1800
181. Smirnova, L., Grafe, A., Seiler, A., Schumacher, S., Nitsch, R., and Wulczyn, F. G. (2005). Regulation of miRNA expression during neural cell specification. Eur. J. Neurosci. 21, 1469-1477. doi: 10.1111/j.1460-9568.2005.03978.x
182. Smith, P., Al Hashimi, A., Girard, J., Delay, C., and Hebert, S. S. (2011). In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs. J. Neurochem. 116, 240-247. doi: 10.1111/j.1471-4159.2010.07097.x
183. Sotiriou, S., Gibney G., Baxevanis AD., and Nussbaum RL. (2009) A single nucleotide polymorphism in the 3'UTR of SNCA gene encoding alphasynuclein is a new potential susceptibility locus for Parkinson's Disease. Neurosci. Lett. 461, 196-201 doi: 10.1016/j.neulet.2009.06.034
184. Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., et al. (2008). TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668-1672. doi: 10.1126/science.1154584
185. Subramanian, S., Lui, W. O., Lee, C. H., Espinosa, I., Nielsen, T. O., Heinrich, M. C., et al. (2008). MicroRNA expression signature of human sarcomas. Oncogene 27, 2015-2026. doi: 10.1038/sj.onc.1210836
186. Sugars, K. L., and Rubinsztein, D. C. (2003). Transcriptional abnormalities in Huntington disease. Trends Genet. 19, 233-238. doi: 10.1016/S0168-9525(03)00074-X
187. Suzuki, H. I., Yamagata, K., Sugimoto, K., Iwamoto, T., Kato, S., and Miyazono, K. (2009). Modulation of microRNA processing by p53. Nature 460, 529-533. doi: 10.1038/nature08199
188. Swantek, J. L., Tsen, M. F., Cobb, M. H., and Thomas, J. A. (2000). IL-1 receptor-associated kinase modulates host responsiveness to endotoxin. J. Immunol. 164, 430-436.
189. Tan, E. K., and Skipper, L. M. (2007). Pathogenic mutations in Parkinson disease. Hum. Mutat. 28, 641-653. doi: 10.1002/humu.20507
190. Tanzi, R., Gaston, S., Bush, A., Romano, D., Pettingell, W., Peppercorn, J., et al. (1993). Genetic heterogeneity of gene defects responsible for familial Alzheimer disease. Genetica 91, 255-263. doi: 10.1007/BF01436002
191. Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., et al. (2008). MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980-984. doi: 10.1038/ nature07511
192. Tomkins, J., Usher, P., Slade, J. Y., Ince, P. G., Curtis, A., Bushby, K., et al. (1998). Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS). Neuroreport 9, 3967-3970. doi: 10.1097/00001756-199812010-00036
193. Uyechi, L. S., Gagne, L., Thurston, G., and Szoka, F. C. Jr. (2001). Mechanism of lipoplex gene delivery in mouse lung: binding and internalization of fluorescent lipid and DNA components. Gene Ther. 8, 828-836. doi: 10.1038/sj.gt.3301461
194. Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J. J., and Lotvall, J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659. doi: 10.1038/ncb1596
195. Vance, C., Rogelj, B., Hortobagyi, T., De Vos, K. J., Nishimura, A. L., Sreedharan, J., et al. (2009). Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208-1211. doi: 10.1126/science.1165942
196. Van Rooij, E., and Olson, E. N. (2007). MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J. Clin. Invest. 117, 2369-2376. doi: 10.1172/JCI33099
197. Vargas, T., Martinez-Garcia, A., Antequera, D., Vilella, E., Clarimon, J., Mateo, I., et al. (2011). IGF-I gene variability is associated with an increased risk for AD. Neurobiol. Aging 32, 556 e553-e511. doi: 10.1016/j.neurobiolaging.2010.10.017
198. Vetrivel, K. S., Cheng, H., Kim, S. H., Chen, Y., Barnes, N. Y., Parent, A. T., et al. (2005). Spatial segregation of gamma-secretase and substrates in distinct membrane domains. J. Biol. Chem. 280, 25892-25900. doi: 10.1074/jbc.M503570200
199. Vilardo, E., Barbato, C., Ciotti, M., Cogoni, C., and Ruberti, F. (2010). MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons. J. Biol. Chem. 285, 18344-18351. doi: 10.1074/jbc.M110.112664
200. Vossel, K. A., Zhang, K., Brodbeck, J., Daub, A. C., Sharma, P., Finkbeiner, S., et al. (2010). Tau reduction prevents Abeta-induced defects in axonal transport. Science 330, 198. doi: 10.1126/science.1194653
201. Wang, D., Lu, M., Miao, J., Li, T., Wang, E., and Cui, Q. (2009). Cepred: predicting the co-expression patterns of the human intronic microRNAs with their host genes. PLoS ONE 4:e4421. doi: 10.1371/journal.pone.0004421
202. Wang, G., Van Der Walt, J. M., Mayhew, G., Li, Y. J., Zuchner, S., Scott, W. K., et al. (2008a). Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am. J. Hum. Genet. 82, 283-289. doi: 10.1016/j.ajhg.2007.09.021
203. Wang, W. X., Rajeev, B. W., Stromberg, A. J., Ren, N., Tang, G., Huang, Q., et al. (2008b). The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J. Neurosci. 28, 1213-1223. doi: 10.1523/JNEUROSCI.5065-07.2008
204. Wang, J., Zhang, P. C., Lu, H. F., Ma, N., Wang, S., Mao, H. Q., et al. (2002). New polyphosphoramidate with a spermidine side chain as a gene carrier. J. Control. Release 83, 157-168. doi: 10.1016/S0168-3659(02)00180-3
205. Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., and Kirschner, M. W. (1975). A protein factor essential for microtubule assembly. Proc. Natl. Acad. Sci. U.S.A. 72, 1858-1862. doi: 10.1073/pnas.72.5.1858
206. Whitehead, K. A., Langer, R., and Anderson, D. G. (2009). Knocking down barriers: advances in siRNA delivery. Nat. Rev. Drug Discov. 8, 129-138. doi: 10.1038/nrd2742
207. Williams, A. H., Valdez, G., Moresi, V., Qi, X., Mcanally, J., Elliott, J. L., et al. (2009). MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326, 1549-1554. doi: 10.1126/science.1181046
208. Wislet-Gendebien, S., Visanji, N. P., Whitehead, S. N., Marsilio, D., Hou, W., Figeys, D., et al. (2008). Differential regulation of wild-type and mutant alphasynuclein binding to synaptic membranes by cytosolic factors. BMC Neurosci. 9:92. doi: 10.1186/1471-2202-9-92
209. Wood, J. G., Mirra, S. S., Pollock, N. J., and Binder, L. I. (1986). Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau). Proc. Natl. Acad. Sci. U.S.A. 83, 4040-4043. doi: 10.1073/pnas.83.11.4040
210. Wood-Kaczmar, A., Gandhi, S., and Wood, N. W. (2006). Understanding the molecular causes of Parkinson's disease. Trends Mol. Med. 12, 521-528. doi: 10.1016/j.molmed.2006.09.007
211. Zhang, C. (2012). Natural compounds that modulate BACE1-processing of amyloid-beta precursor protein in Alzheimer's disease. Discov. Med. 14, 189-197.
212. Zhang, Y. W., Thompson, R., Zhang, H., and Xu, H. (2011). APP processing in Alzheimer's disease. Mol. Brain 4, 3. doi: 10.1186/1756-6606-4-3
213. Zhao, J., Sun, B. K., Erwin, J. A., Song, J. J., and Lee, J. T. (2008). Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 322, 750-756. doi: 10.1126/science.1163045
214. Zhu, H. C., Wang, L. M., Wang, M., Song, B., Tan, S., Teng, J. F., et al. (2012). MicroRNA-195 downregulates Alzheimer's disease amyloidbeta production by targeting BACE1. Brain Res. Bull. 88, 596-601. doi: 10.1016/j.brainresbull.2012.05.018
215. Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., et al. (2004). Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601-607. doi: 10.1016/j.neuron.2004.11.005
216. Zomer, A., Vendrig, T., Hopmans, E. S., Van Eijndhoven, M., Middeldorp, J. M., and Pegtel, D. M. (2010). Exosomes: fit to deliver small RNA. Commun. Integr. Biol. 3, 447-450. doi: 10.4161/cib.3.5.12339
217. Zong, Y., Wang, H., Dong, W., Quan, X., Zhu, H., Xu, Y., et al. (2011). miR-29c regulates BACE1 protein expression. Brain Res. 1395, 108-115. doi: 10.1016/j.brainres.2011.04.035
218. Zuccato, C., Tartari, M., Crotti, A., Goffredo, D., Valenza, M., Conti, L., et al. (2003). Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat. Genet. 35, 76-83. doi: 10.1038/ ng1219
219. Zuccato, C., Valenza, M., and Cattaneo, E. (2010). Molecular mechanisms and potential therapeutical targets in Huntington's disease. Physiol. Rev. 90, 905-981. doi: 10.1152/physrev.00041.2009